Osteoporosis and polypharmacy
Authors:
- 19 July 2012
- journal article
- review article
- Published by Springer Nature in Zeitschrift für Gerontologie und Geriatrie
- Vol. 45 (6) , 450-454
Abstract
Osteoporosis is very common in elderly patients. Despite the severe health-related consequences for individual patients and the socioeconomic costs caused by osteoporotic fractures, treatment rates are still low. Due to drug interactions and patient compliance, polypharmacy is often mentioned as a reason for undertreatment. Several drugs have a direct or indirect effect on bone metabolism. The present paper discusses the risk of interactions of anti-osteoporotic drugs (oral and parenteral bisphosphonates, raloxifene, strontium ranelate, teriparatide, and denosumab) with other common medications in elderly patients and their impact on bone metabolism and fracture risk. In summary, the number and risk of drug interactions of all common anti-osteoporotic drugs are small and clinically rather irrelevant. However, patients with a polypharmacy are at a higher risk of fractures and should receive osteoporosis treatment, if indicated. Osteoporose hat eine hohe Prävalenz bei älteren Patienten. Trotz der enormen individuellen Folgen für die Betroffenen und die hohen sozioökonomischen Kosten osteoporotischer Frakturen sind die Therapieraten weiterhin sehr gering. Als Begründung wird immer wieder die Polypharmazie genannt, insbesondere im Hinblick auf mögliche Medikamenteninteraktionen sowie die Compliance. Zahlreiche Medikamente haben einen direkten oder indirekten Einfluss auf den Knochenmetabolismus. Im vorliegenden Review wird die Bedeutung möglicher Interaktionen diskutiert sowie das Frakturrisiko im Rahmen einer Polypharmazie dargestellt. Einerseits zeigt sich, dass das Interaktionspotenzial der zugelassenen Osteoporosemedikamente gering ist. Andererseits haben Patienten mit einer Polypharmazie ein erhöhtes Frakturrisiko und sollten eine Osteoporosetherapie erhalten, wenn diese indiziert ist.Keywords
This publication has 51 references indexed in Scilit:
- Cardiovascular, Ocular and Bone Adverse Reactions Associated with ThiazolidinedionesDrug Safety, 2012
- Surgery for fragility hip fracture—streamlining the processOsteoporosis International, 2010
- Missed Opportunities for Osteoporosis Treatment in Patients Hospitalized for Hip FractureJournal of the American Geriatrics Society, 2010
- Effects of selective serotonin reuptake inhibitors on bone health in adults: Time for recommendations about screening, prevention and management?Bone, 2010
- Loop Diuretic Use and Rates of Hip Bone Loss and Risk of Falls and Fractures in Older WomenJournal of the American Geriatrics Society, 2009
- PPARγ in human and mouse physiologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Is inappropriate medication use a major cause of adverse drug reactions in the elderly?British Journal of Clinical Pharmacology, 2006
- Epidemiologie von Stürzen ÄltererZeitschrift für Orthopädie und ihre Grenzgebiete, 1999
- Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.Journal of the American College of Nutrition, 1995
- Morbidity in patients on l‐thyroxine: a comparison of those with a normal TSH to those with a suppressed TSHClinical Endocrinology, 1992